Selskabets formål er at importere, eksportere, producere hos underleverandører, lagerføre, engroshandel, agenturhandel og salg af diagnostiske produkter, ethanol, lægemidler, naturmedicin, næringsstoffer, kosmetiske produkter, sundhedsplejeprodukter og hospitalsudstyr- og materiel, såvel som at udføre tjenesteydelser i forbindelse hermed og i forbindelse med medicinsk videnskab, konsulentydelser, kursusvirksomhed og materieludlejning samt produktion af IT-programmer. Selskabet har endvidere til formål at eje og besidde fast ejendom og værdipapirer.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 14.9 mio. | 108 t. | 4.2 mio. | 3.1 mio. | 1 | |
CVR: 28292090
Secondary names: ALGOL PHARMAMED ApS, ALGOL PHARMA ApS
Companies in the same industry and area
CVR 35035524
CVR 35203176
CVR 28248679
CVR 44869764
CVR 44012871
Compared to 157 companies in Agenturhandel med specialiseret varesortiment, bortset fra køretøjer
Comparison is based on industry median values
HISTOLAB PRODUCTS ApS exhibits a stable financial health with consistent revenue generation, showing an upward trend in both revenue and profit over the past five years. In 2025, the company reported revenue of 14,888,720 DKK and a profit of 107,970 DKK, marking a slight increase from 14,577,021 DKK in revenue and 59,499 DKK in profit in 2024. The equity position has also improved, reaching 3,130,036 DKK in 2025, indicating a solid foundation for future growth. However, profit margins remain relatively thin, suggesting a need for enhanced operational efficiency. Positioned within the specialized goods agency sector, the company maintains a stable presence, though its growth potential may be limited by competitive pressures and market dynamics.
AI-generated summary
companydata.dk